Staedtler G, et al. - This trial resolved to empirically generate a responder definition for the treatment of papulopustular rosacea. The findings disclosed that the estimated cutoff point of 5.69 lesions, permitted discrimination of responders (5 or less remaining lesions) and nonresponders (6 or more remaining lesions) of therapeutic interventions in rosacea.